Agilent Technologies, Inc. $A Shares Bought by Leeward Investments LLC MA

Leeward Investments LLC MA boosted its stake in Agilent Technologies, Inc. (NYSE:A) by 12.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 101,927 shares of the medical research company’s stock after acquiring an additional 11,173 shares during the period. Leeward Investments LLC MA’s holdings in Agilent Technologies were worth $11,618,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in A. Gabelli Funds LLC increased its stake in Agilent Technologies by 1.1% in the third quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock valued at $850,000 after purchasing an additional 74 shares during the period. Fiduciary Trust Co raised its position in Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after buying an additional 77 shares during the last quarter. NorthCrest Asset Manangement LLC lifted its stake in shares of Agilent Technologies by 1.6% in the 4th quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock worth $726,000 after acquiring an additional 79 shares during the period. Freestone Capital Holdings LLC lifted its stake in shares of Agilent Technologies by 2.0% in the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock worth $574,000 after acquiring an additional 84 shares during the period. Finally, Grove Bank & Trust boosted its holdings in shares of Agilent Technologies by 5.5% in the fourth quarter. Grove Bank & Trust now owns 1,758 shares of the medical research company’s stock valued at $239,000 after acquiring an additional 92 shares in the last quarter.

Agilent Technologies Stock Up 0.4%

Agilent Technologies stock opened at $126.95 on Wednesday. The firm has a market capitalization of $35.85 billion, a price-to-earnings ratio of 25.49, a price-to-earnings-growth ratio of 2.25 and a beta of 1.26. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The stock’s fifty day moving average is $121.94 and its two-hundred day moving average is $126.44.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts predict that Agilent Technologies, Inc. will post 6 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be paid a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies’s dividend payout ratio is presently 20.48%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Piper Sandler assumed coverage on Agilent Technologies in a report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price objective on the stock. Royal Bank Of Canada began coverage on Agilent Technologies in a report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 target price for the company. TD Cowen boosted their target price on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. HSBC reduced their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Finally, Robert W. Baird upped their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 26th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $160.93.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.